project id: TCGA-BRCA; case submitter id: TCGA-BH-A0WA; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.9; spectrophotometer method: UV Spec; age at index: 82; days to birth: -30025; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1926; age at diagnosis: 30025; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage I; ajcc pathologic t: T1c; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 701.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8575/3; primary diagnosis: Metaplastic carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 724; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-BH-A0WA-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent tumor cells: 75.0; percent tumor nuclei: 90.0;